The global Rivastigmine market is estimated to be valued at US$ 594.78 Mn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period of 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength: Rivastigmine is one of the few approved therapies for Alzheimer’s disease which provides symptomatic relief. It...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian